Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Helius Medical Technologies ( (HSDT) ) just unveiled an update.
Helius Medical Technologies is actively pursuing strategic alternatives to enhance shareholder value amid challenges with CMS pricing determinations for its PoNS device. Having engaged B. Riley Securities as an advisor, the company is exploring options like mergers or sales, while also addressing reimbursement issues to better position its innovative neuromodulation therapy in the market.
For a thorough assessment of HSDT stock, go to TipRanks’ Stock Analysis page.